{"nct_id":"NCT02447328","title":"A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2015-05-29","start_date_type":"ACTUAL","primary_completion_date":"2016-05-06","primary_completion_date_type":"ACTUAL","completion_date":"2020-09-16","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["AZN"]}